SynthesisCurrent urology reports2021
Primary Renal Synovial Sarcoma and Clinical and Pathological Findings: a Systematic Review.
Synthesis in Current urology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 19 citations in OpenAlex.
- Development and validation of a prognostic nomogram for adult patients with renal sarcoma: A retrospective study based on the SEER database.Frontiers in public health · 2022Trial
- A Case of Primary Synovial Sarcoma of the Posterior Mediastinum: From Diagnostic Challenges to the Surgical Approach.Journal of chest surgery · 2026Article
- Primary renal synovial sarcoma presenting with tumor rupture and extensive intra-abdominal dissemination: A case report and literature review.Urology case reports · 2026Article
- Primary renal synovial sarcoma: a clinicopathological study of 23 cases highlighting the diagnostic value of SS18-SSX, TLE1, and INI1 immunohistochemistry panel.Virchows Archiv : an international journal of pathology · 2026Article
- Article
- Case Report: A case of primary renal synovial sarcoma.Frontiers in surgery · 2026Article
- Primary renal synovial sarcoma with synchronous pulmonary metastases: A rare case report and review of diagnostic and management strategies.Urology case reports · 2025Article
- Article
- Renal synovial sarcoma: Considerations for radical nephrectomy- a case report and literature review.Urology case reports · 2024Article
- A Case report: Synovial sarcoma of the mediastinum in an 18-year-old teenager.Frontiers in oncology · 2024Article
- An Extremely Rare and Demanding Diagnosis of Primary Renal Synovial Sarcoma: A Case Report.Cureus · 2023Article
- Primary Synovial Sarcoma of the Kidney: Diagnostic Approach and Therapeutic Modalities for a Rare Nosological Entity.Journal of personalized medicine · 2022Review
- Primary Renal Synovial Sarcoma Presenting as Haemorrhagic Shock: A Rare Presentation.Journal of kidney cancer and VHL · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTo update epidemiological, diagnostic, and therapeutic information on primary synovial sarcoma of the kidney. RECENT
findingsA total of 96 studies were analyzed; age at presentation was 38.6±14.2 years, predominant location of tumor was right kidney; frequent reported symptoms at diagnosis were hematuria and pain. For definitive diagnosis, cytogenetic technique was used. Detected oncogene was available in 37.8% cases with fusion of SS18-SSX in most patients. Surgery is treatment of choice, with adjuvant chemotherapy; most frequently ifosfamide-based associated with doxorubicin or epirubicin. Overall median survival was 34 months. Mortality was 29% of the cases which reported death and the recurrence rate was 39.8%. Risk of death was increased in patients with metastases at diagnosis Primary RSS occurs more often in young men. RSS often presents with symptoms and in an advanced stage. Surgical treatment is the most commonly used and chemotherapy for advanced or recurrent treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.